Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 96,295 | 54,080 | 48,906 | 10,669 | 16,387 |
| Other current assets | 234 | 88 | 2,853 | 2,915 | 2,698 |
| TOTAL | $101,154 | $55,032 | $52,112 | $14,516 | $20,953 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,698 | 1,134 | 909 | 797 | 867 |
| TOTAL | $1,698 | $1,134 | $909 | $797 | $867 |
| Total Assets | $102,852 | $56,166 | $53,021 | $15,313 | $21,820 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,500 | 1,000 | N/A | 539 | 943 |
| Accounts payable and accrued liabilities | 1,209 | 2,683 | 943 | 1,386 | 807 |
| Accrued Expenses | 7,254 | 8,101 | 9,143 | 7,502 | 6,310 |
| TOTAL | $10,963 | $11,784 | $10,086 | $9,427 | $8,060 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,591 | 5,464 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 3,568 | 4,270 | 419 | 500 | 580 |
| TOTAL | $8,159 | $9,734 | $419 | $500 | $580 |
| Total Liabilities | $19,122 | $21,518 | $10,505 | $9,927 | $8,640 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,874 | 2,752 | 1,372 | 1,070 | 563 |
| Retained earnings | -317,729 | -301,500 | -289,234 | -274,588 | -266,376 |
| TOTAL | $83,730 | $34,648 | $42,516 | $5,386 | $13,180 |
| Total Liabilities And Equity | $102,852 | $56,166 | $53,021 | $15,313 | $21,820 |